Efficacy of sufentanil in urgent laparoscopic cholecystectomy: An alternative to the usual opioids for postoperative pain?

Status

Not yet recruiting

Phases

Phase 3

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2026-525783-18-00

Enrollment

Registered

2026-06-08

Start date

Unknown

Completion date

Unknown

Last updated

2026-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Laparoscopic cholecystectomy

Brief summary

Visual Analogue Scale (VAS)

Detailed description

Age, Sex, Weight, Height, ASA, VAS at the first postoperative hour, VAS at the second postoperative hour, VAS at the 12th postoperative hour, Postoperative nausea or vomiting, Pruritus, Respiratory depression, Micrograms of opioids administered during surgery, Opioid use in the first 24 hours

Interventions

DRUGSUFENTANIL

DRUGFENTANYL

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Design outcomes

Primary

Measure	Time frame
Visual Analogue Scale (VAS)	—

Secondary

Measure	Time frame
Age, Sex, Weight, Height, ASA, VAS at the first postoperative hour, VAS at the second postoperative hour, VAS at the 12th postoperative hour, Postoperative nausea or vomiting, Pruritus, Respiratory depression, Micrograms of opioids administered during surgery, Opioid use in the first 24 hours	—

Outcome results

None listed

Source: EU CTIS · Data processed: Jun 9, 2026